Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1T90
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,285
Award facts
- Contract value 100% obligated
- $29,284.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 9, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $29.3K to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SureClick auto-injectors. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by January 12, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., one of the nation's largest pharmaceutical distributors serving federal government healthcare systems.
This delivery order is executed under Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive global pharmaceutical support vehicle valued through December 2031 that enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and specialized auto-injectors across multiple therapeutic domains. ENBREL (etanercept) is a biologic immunosuppressant used in treating inflammatory conditions such as rheumatoid arthritis and is a standard pharmaceutical item in military medical supply chains. This award reflects the contractor's demonstrated capability to fulfill federal procurement requirements for essential pharmaceutical products on a competitive, non-set-aside basis.
Quick answers
Who was awarded contract SPE2DR26F1T90?
SPE2DR26F1T90 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F1T90 worth?
The government has obligated $29,285 on SPE2DR26F1T90.
Is contract SPE2DR26F1T90 an order under another contract?
Yes. SPE2DR26F1T90 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1T90 competed?
The extent of competition for SPE2DR26F1T90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award